Prediction of conversion from mild cognitive impairment to Alzheimer's disease by CSF cytochrome c levels and N200 latency

Current Alzheimer Research

Volumn 6, Issue 3, 2009, Pages 279-284

  Papaliagkas, V T ^a   Anogianakis, G ^a   Tsolaki, M N ^a   Koliakos, G ^a   Kimiskidis, V K ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Alzheimer's disease; Auditory event related potentials; Cytochrome c; Mild cognitive impairment; N200 latency

Indexed keywords

CYTOCHROME C;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; EVOKED AUDITORY RESPONSE; FEMALE; FOLLOW UP; HUMAN; LATENT PERIOD; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL;

ACOUSTIC STIMULATION; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; COGNITION DISORDERS; CYTOCHROMES C; DISEASE PROGRESSION; ELECTROENCEPHALOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REACTION TIME;

EID: 67149136863     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720509788486626     Document Type: Article

References (43)

1. Jellinger KA. Challenges in neuronal apoptosis. Curr Alzheimer Res 3: 377-391 (2006). (Pubitemid 44351481)
2. Papaliagkas V, Anogianaki A, Anogianakis G, Ilonidis G. The proteins and the mechanisms of apoptosis: A mini-review of the fundamentals. Hippokratia 11:108-113 (2007). (Pubitemid 47124247)
3. Cribbs DH, Poon WW, Rissman RA, Blurton-Jones M. Caspase-mediated degeneration in Alzheimer's disease. Am J Pathol 165: 353-355 (2004). (Pubitemid 38971367)
4. Rohn TT, Head E, Su JH, Anderson AJ, Bahr BA, Cotman CW, et al. Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease. Am J Pathol 158: 189-198 (2001). (Pubitemid 32096484)
5. Bayir H, Fadeel B, Palladino MJ, Witasp E, Kurnikov IV, Tyurina YY, et al. Apoptotic interactions of cytochrome c: redox flirting with anionic phospholipids within and outside of mitochondria. Biochim Biophys Acta 1757: 648-659 (2006). (Pubitemid 43996945)
6. Gonzales DH and Neupert W. Biogenesis of mitochondrial c-type cytochromes. J Bioenerg Biomembr 22: 753-768 (1990).
7. Eckert A, Marques CA, Keil U, Schüssel K and Müller WE. Increased apoptotic cell death in sporadic and genetic Alzheimer's disease. Ann NY Acad Sci 1010: 604-609 (2003). (Pubitemid 38265054)
8. Smale G, Nichols NR, Brady DR, Finch CE, Jr Horton WE. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 133: 225-230 (1995).
9. Jiang XJ, Wang XD. Cytochrome c-mediated apoptosis. Annu Rev Biochem 73: 87-106 (2004).
10. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136 (1997). (Pubitemid 27097313)
11. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132 (1997). (Pubitemid 27097312)
12. Adrain C, Martin SJ. The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem Sci 26: 390-397 (2001). (Pubitemid 32530658)
13. Woodhouse A, Vickers JC, Dickson TC. Cytoplasmic cytochrome c immunolabelling in dystrophic neuritis in Alzheimer's disease. Acta Neuropathol 112: 429-437 (2006). (Pubitemid 44469163)
14. Blanchard V, Moussaoui S, Czech C, Touchet N, Bonici B, Planche M, et al. Time sequence of maturation of dystrophic neurites associated with A deposits in APP/PS1 transgenic mice. Exp Neurol 184: 247-263 (2003). (Pubitemid 37444035)
15. Kim HS, Lee JH, Lee JP. Amyloid [beta] peptide induces cytochrome c release from isolated mitochondria. Neuroreport 13: 1989-1993 (2002).
16. Agin V, Chicher R, Chichery MP. Effects of learning on cytochrome oxidase activity in cuttlefish brain. Neuroreport 12: 113-116 (2001). (Pubitemid 32099038)
17. Berndt JD, Callaway NL, Gonzalez-Lima F. Effects of chronic sodium azide on brain and muscle cytochrome oxidase activity: a potential model to investigate environmental contributions to neurodegenerative diseases. J Toxicol Environ Health A 63: 67-77 (2001). (Pubitemid 32391857)
18. Cada A, Gonzalez-Lima F, Rose GM, Bennett MC. Regional brain effects of sodium azide treatment on cytochrome oxidase activity: a quantitative histochemical study. Metab Brain Dis 10: 303-320 (1995). (Pubitemid 26042539)
19. Woodhouse A, Dickson TC, West AK, McLean CA, Vickers JC. No difference in expression of apoptosis-related proteins and apoptotic morphology in control, pathologically aged and Alzheimer's disease cases. Neurobiol Dis 22: 323-333 (2006).
20. Banquet JP, Guenther W, Smith M. Probability processing in depressed patients. Electroencephalogr Clin Neurophysiol Suppl 40: 645-650 (1987).
21. Alho K. Cerebral generators of mismatch negativity (MMN) and its magnetic counterpart (MMNm) elicited by sound changes. Ear Hear 16: 38-51 (1995).
22. Folstein M, Folstein S, McHugh P. Mini-Mental State' A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198 (1975).
23. Fountoulakis K, Tsolaki M, Chantzi H, Kazis A. Mini-Mental State Examination (MMSE): A validation study in the Greek elderly population. Encephalos (Greece) 31: 93-102 (1994).
24. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56: 303-308 (1999). (Pubitemid 29120227)
25. Katsarou Z, Bostantjopoulou S, Kimiskidis V, Rossopoulos E, Kazis A. Auditory event-related potentials in Parkinson's disease in relation to cognitive ability. Percept Mot Skills 98: 1441-1448 (2004). (Pubitemid 39110199)
26. Squires KC, Wickens C, Squires NK, Donchin E. The effect of stimulus sequence on the waveform of the cortical event-related potential. Science 193: 1142-1146 (1976).
27. Papaliagkas VT, Kimiskidis VK, Tsolaki MN, Anogianakis G. Usefulness of event-related potentials in the assessment of mild cognitive impairment. BMC Neurosci 9: 107 (2008).
28. Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB. Progression to dementia in patients with isolated memory loss. Lancet 349: 763-765 (1997). (Pubitemid 27122459)
29. Petersen RC. Mild cognitive impairment clinical trials. Nat Rev Drug Discov 2: 646-653 (2003). (Pubitemid 37361768)
30. de la Monte SM, Sohn YK, Wands JR. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J Neurol Sci 152: 73-83 (1997). (Pubitemid 27469712)
31. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157 (1996). (Pubitemid 26256586)
32. Shimohama S. Apoptosis in Alzheimer's disease-an update. Apoptosis 5: 9-16 (2000).
33. Kitamura Y, Shimohama S, Kamoshima W, Ota T, Matsuoka Y, Nomura Y, et al. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32 in Alzheimer's disease. Brain Res 780: 260-269 (1998). (Pubitemid 28082914)
34. Nagy ZS, Esiri MM. Apoptosis-related protein expression in the hippocampus in Alzheimer's disease. Neurobiol Aging 18: 565-571 (1997). (Pubitemid 28046409)
35. Rohn TT, Head E, Nessen WH, Cotman CE, Cribbs DH. Activation of caspase-8 in the Alzheimer's disease brain. Neurobiol Dis 8: 1006-1016 (2001). (Pubitemid 34017094)
36. Rohn TT, Rissman RA, Davis MC, Kim YE, Cotman CW, Head E. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Neurobiol Dis 11: 341-354 (2002). (Pubitemid 36135697)
37. Satou T, Cummings BJ, Cotman CW. Immunoreactivity for Bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity. Brain Res 697: 35-43(1995).
38. Stadelmann C, Deckwerth TL, Srinivasan A, Bancher C, Bruck W, Jellinger K, et al. Activation of caspase-3 in single neurons and autophagic granules of granulovacular degeneration in Alzheimer's disease. Am J Pathol 155: 1459-1466 (1999).
39. Su JH, Deng G, Cotman CW. Bax protein expression is increased in Alzheimer's brain: correlations with DNA damage, Bcl-2 expression, and brain pathology. J Neuropathol Exp Neurol 56: 86-93 (1997). (Pubitemid 127470330)
40. Zhao M, Su J, Head E, Cotman CW. Accumulation of caspase cleaved amyloid precursor protein represents an early neurodegenerative event in aging and in Alzheimer's disease. Neurobiol Dis 14: 391-401 (2003). (Pubitemid 37543518)
41. Bennys K, Portet F, Touchon J, Rondouin G. Diagnostic value of event-related evoked potentials N200 and P300 subcomponents in early diagnosis of Alzheimer's disease and mild cognitive impairment. J Clin Neurophysiol 24: 405-412 (2007). (Pubitemid 47524880)
42. Missonnier P, Deiber MP, Gold G, Herrmann FR, Millet P, Michon A, et al. Working memory load-related electroencephalographic parameters can differentiate progressive from stable mild cognitive impairment. Neuroscience 150: 346-356 (2007). (Pubitemid 350198709)
43. Allison T, Puce A, McCarthy G. Category-sensitive excitatory and inhibitory processes in human extrastriate cortex. J Neurophysiol 88: 2864-2868 (2002). (Pubitemid 35346082)